Feb 14, 2022 - Feb 17, 2022 / NTS GMT
Presentation
Feb 14, 2022 - Feb 17, 2022 / NTS GMT
=====================
Corporate Participants
=====================
* Seth Lederman
Tonix Pharmaceuticals Holding Corp. - Co-Founder, CEO & Chairman
=====================
Seth Lederman - Tonix Pharmaceuticals Holding Corp. - Co-Founder, CEO & Chairman
Hello. I'm Seth Lederman, CEO of Tonix Pharmaceuticals. Thank you for attending this presentation. We're a public company on NASDAQ, and I will be making forward-looking statements, so I refer you to our SEC filings for more complete information about the company.
It's a very exciting year for Tonix. We have a pipeline that's broad but fits into two main categories. The first is our infectious disease and immunology platforms. And of those, we have a number of programs on COVID that I'm going to be focusing on today. And in addition to the immunology portfolio, we have a pipeline of programs in the central nervous system category, and I'll be briefly talking about those at the end.
So speaking about our infectious
Tonix Pharmaceuticals Holding Corp at Biotechnology Industry Organization (BIO) CEO & Investor Conference (Virtual) - Virtual Presentation Transcript
Feb 14, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers